Technology | June 05, 2006

Technology Integrated to Enhance Treatment of Cardiac Arrhythmias, Provide Reference Point

A combination of technologies can enhance a doctor’s ability to treat patients with abnormal heart rhythms. The NaviStar RMT Diagnostic/Ablation Steerable Tip Catheter has been FDA cleared for integration with the Niobe Magnetic Navigation System and the Carto RMT.
The integrated products enable electrophysiologists to steer a catheter remotely, map the electrical activity of the heart and ablate targeted areas that require treatment.
In addition, the catheter provides a reliable reference point within the Carto RMT System to ensure an accurate visual framework for mapping diagnostic procedures.


Additional Content

News | Catheters

Nov. 4, 2026 — Evident Vascular has announced U.S. Food and Drug Administration (FDA) 510(k) clearance of the Evident ...

Home November 05, 2026
Home
News | Catheters

Sept. 14, 2026 — Interventional Medical Device Solutions (IMDS), has announced the U.S. launch of NHanceIT, an over-the ...

Home September 15, 2026
Home
News | Catheters

June 30, 2026 — Penumbra Inc. has received the CE Mark for Red 72 Silver Label and Red 72 Silver Label with SENDit ...

Home July 02, 2026
Home
News | Catheters

Feb. 12, 2026 – CellProthera has acquired the transendocardial catheter originally developed by Celyad Oncology. This ...

Home February 12, 2026
Home
News | Catheters

Oct. 23, 2025— Emboline, Inc., a provider of full-body embolic protection devices for transcatheter procedures, thas ...

Home October 28, 2025
Home
Subscribe Now